Aging Population And Chronic Illnesses Will Expand Post-Acute Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
11 May 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
US$21.00
36.1% undervalued intrinsic discount20 Aug
US$13.42
1Y
-62.3%7D
5.6%